Skip to main content

2020 to 2022 Saw Increase in Enrollment in Medical Cannabis Programs

Medically reviewed by Carmen Pope, BPharm. Last updated on April 9, 2024.

By Elana Gotkine HealthDay Reporter

MONDAY, April 8, 2024 -- From 2020 to 2022, there was an increase in enrollment in medical cannabis programs but a decrease in jurisdictions with nonmedical adult-use laws, according to a study published online April 9 in the Annals of Internal Medicine.

Kevin F. Boehnke, Ph.D., from the Chronic Pain and Fatigue Research Center at the University of Michigan Medical School in Ann Arbor, and colleagues describe current trends in medical cannabis licensure in the United States in an ecological study with repeated measures.

Thirty-nine jurisdictions allowed medical cannabis use in 2022; 34 reported patient numbers, 19 reported patient-qualifying conditions, and 29 reported authorizing clinician numbers. The researchers found that enrolled patients increased 33.3 percent, from 3,099,096 in 2020 to 4,132,098 in 2022, with a corresponding increase of 23.0 percent in the population prevalence of patients (175.0 to 215.2 per 10,000 patients). Decreased enrollment was seen in 13 of 15 jurisdictions with nonmedical adult-use laws. From 2020 to 2022, the proportion of patient-reported qualifying conditions with substantial or conclusive evidence of therapeutic value decreased from 70.4 to 53.8 percent. The most common patient-reported qualifying condition in 2022 was chronic pain, followed by anxiety and posttraumatic stress disorder (48.4, 14.2, and 13.0 percent, respectively).

"Improved reporting efforts from states on patient characteristics (such as cannabis use patterns and length of use) as well as clinician credentials and training may help enhance understanding of this rapidly shifting medical cannabis use landscape," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted April 2024

Read this next

Researchers Compare Race-Based, Race-Neutral Lung Function Equations

TUESDAY, May 21, 2024 -- The use of race-based and race-neutral equations for lung-function testing generate similarly accurate predictions of respiratory outcomes, but differ in...

Survival Benefit for Cancer Trial Participants Does Not Persist in Adjusted Analyses

TUESDAY, May 21, 2024 -- In studies using designs addressing sources of bias and confounding, there is no evidence of a survival benefit for cancer trial participants, according...

Genital Talc Use Positively Linked to Ovarian Cancer

TUESDAY, May 21, 2024 -- There is a positive association between use of intimate care products, including genital talc, and ovarian cancer, according to a study published online...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.